JMS Co.,Ltd. (7702.T) Stock

7702.T logo

JMS Co.,Ltd.

7702.TJapan
Healthcare

Company profile

JMS reported revenue of 69.75 billion JPY for fiscal year 2025, up 6.8% from fiscal year 2024. Its largest business segment, Japan, brought in 51% of segment revenue in fiscal year 2025; Japan was the largest region with 57%. Our analysis of its filings shows revenue growing from 63.74 billion JPY in fiscal year 2023 to 69.75 billion JPY in fiscal year 2025, 4.6% a year on average. JMS reports about 4,887 full-time employees.

What stands out

  • It returned to a profit in fiscal year 2025, 89.00 million JPY, after a net loss of 36.00 million JPY in fiscal year 2024.
  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended March 31, 2025.

About JMS Co.,Ltd.

JMS Co.,Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals in Japan, Asia, North America, Europe, China, South Korea, Thailand, and internationally. It offers infusion and nutrition solutions, which includes needless access port, closed drug mixing and infusion system, infusion pump, and oral and enteral nutrition system for treatment and laboratory testing; and dialysis solutions including dialysis equipment for hemodialysis, peritoneal dialysis solution, and APD equipment that automatically performs the injection and discharge of peritoneal dialysis solution, as well as offers hemodialysis machines. It also provides surgical treatment solution comprising products that are used in cardiac surgery and cardiovascular internal medicine, such as membrane oxygenator and cardiopulmonary blood pump systems. In addition, the company offers blood management and cell therapy solutions, which includes serum collection sets and blood bags. Further, it provides logistics and other equipment; and offers maintenance works and sanatorium services. The company was incorporated in 1947 and is headquartered in Hiroshima, Japan.

Largest shareholders

  • Kaneka Corporation10.27%
  • Tsuchiya Foundation7.68%
  • Saeko Tsuchiya4.075 %4.08%
  • Senjukai Foundation4.04%
  • Hirogin Holdings, Inc.3.62%

Share of the company, as of September 25, 2026

Leadership

  • Ryuji Katsura — President & Representative Director, 62
  • Yasuhiro Awane — EVP, GM of Corporate Strategy & Surgical & Therapy Business Unit, Head of Sales and Director, 64
  • Tohru Sakoda — Head of Global Marketing Division & Director, 59
  • Shogo Yanagida — Head of Production Division & Director, 62
  • Raita Uematsu — Head of Research & Development Division and Director, 58

How much revenue does JMS make?

JMS reported 69.75 billion JPY in revenue for fiscal year 2025, up 6.8% from 65.29 billion JPY in fiscal year 2024.

What is JMS's largest business segment?

Japan, with 46.03 billion JPY or 51% of segment revenue in fiscal year 2025. Next: Singapore (30%) and Others (6%).

Where does JMS make most of its revenue?

Japan: 57% of revenue by region in fiscal year 2025, followed by Asia (18%).

What companies are similar to JMS?

Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Mani, Inc. (7730.T), Medikit Co.,Ltd. (7749.T), Japan Tissue Engineering Co., Ltd. (7774.T), Create Medic Co., Ltd. (5187.T).

Has JMS made a profit in recent years?

Net income by fiscal year: FY2021, 1.74 billion JPY; FY2022, 826.00 million JPY; FY2023, 281.00 million JPY; FY2024, a loss of 36.00 million JPY; FY2025, 89.00 million JPY. It reported a net loss in 1 of these 5 years.

How has JMS's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 57.58 billion JPY; FY2022, 58.17 billion JPY; FY2023, 63.74 billion JPY; FY2024, 65.29 billion JPY; FY2025, 69.75 billion JPY.

Company Information

SectorHealthcare
IndustryVarious Healthcare Equipment Manufacturing
Employees4,887
FoundedSep 3, 1947
IPO DateMar 13, 1989
IPO StatusPublic
HeadquartersHiroshima, Japan
ExchangeTokyo
TimezoneAsia/Tokyo (JST)

Contact & Links

Address
12-17 Kako-machi, Hiroshima, 730-8652
Phone
81 8 2243 5844
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “JMS Co.,Ltd. (7702.T)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/7702.T

LinkedInLinkedInXXYouTubeYouTube